Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales

about

Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales

Item

http://www.wikidata.org/entity/Q58613140

description

article

@en

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Cost-utility analysis of searc ...... erolaemia in England and Wales

@en

Cost-utility analysis of searc ...... erolaemia in England and Wales

@nl

type

Item

label

Cost-utility analysis of searc ...... erolaemia in England and Wales

@en

Cost-utility analysis of searc ...... erolaemia in England and Wales

@nl

prefLabel

Cost-utility analysis of searc ...... erolaemia in England and Wales

@en

Cost-utility analysis of searc ...... erolaemia in England and Wales

@nl

P1476

Cost-utility analysis of searc ...... erolaemia in England and Wales

@en

P2093

Hugh McGuire

http://www.w3.org/2001/XMLSchema#string

Ross Maconachie

http://www.w3.org/2001/XMLSchema#string

Sara Buckner

http://www.w3.org/2001/XMLSchema#string

Steve E Humphries

http://www.w3.org/2001/XMLSchema#string

P2860

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Diagnostic scoring for familial hypercholesterolaemia in practice.

Genetic Architecture of Familial Hypercholesterolaemia.

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study

The epidemiology of cardiovascular disease in the UK 2014

Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK.

P304

80-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2018.05.021

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

275

http://www.w3.org/2001/XMLSchema#string

P50

Nadeem Qureshi

Paul Crosland

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29879685

http://www.w3.org/2001/XMLSchema#string

P921

electronic health record

hypercholesterolemia

P932

6116897

http://www.w3.org/2001/XMLSchema#string